Back to Search
Start Over
Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient
- Source :
- Journal of Neurology
- Publication Year :
- 2020
- Publisher :
- Springer Berlin Heidelberg, 2020.
-
Abstract
- Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic. Acute respiratory syndrome seems to be the most common manifestation of COVID-19. Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury. To our knowledge, among neurological disorders associated with SARS-CoV2 infection, no Posterior Reversible Encephalopathy Syndrome (PRES) has been described yet. Herein, we report a case of a 64-year old woman with COVID19 infection who developed a PRES, and we suggest that it could be explained by the disruption of the blood brain barrier induced by the cerebrovascular endothelial dysfunction caused by SARS-CoV-2.
- Subjects :
- Pathology
medicine.medical_specialty
Encephalopathy
Clinical Neurology
Endothelial dysfunction
COVID-19
Reversible encephalopathy syndrome PRES
Blood–brain barrier
Letter to the Editors
03 medical and health sciences
0302 clinical medicine
Medicine
030212 general & internal medicine
Respiratory system
Stroke
business.industry
Outbreak
Posterior reversible encephalopathy syndrome
medicine.disease
Pneumonia
medicine.anatomical_structure
Neurology
Neurology (clinical)
business
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- ISSN :
- 14321459 and 03405354
- Database :
- OpenAIRE
- Journal :
- Journal of Neurology
- Accession number :
- edsair.doi.dedup.....f49147d35da9cde2c27be4c3a0d2456a